Loading...
The Impact of the Orphan Drug Act on FDA-Approved Therapies for Rare Skin Diseases and Skin-Related Cancers
The Orphan Drug Act of 1983 (ODA) put in place a set of financial and marketing incentives to stimulate the development of drugs to treat rare diseases, and since its passage more than 600 orphan drug and biologic products have been brought to market in the United States. Rapid growth in orphan drug...
Na minha lista:
| Udgivet i: | J Am Acad Dermatol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6857728/ https://ncbi.nlm.nih.gov/pubmed/31103566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2019.05.025 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|